Mayflower Financial Advisors LLC Takes $256,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Mayflower Financial Advisors LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 431 shares of the biotechnology company’s stock, valued at approximately $256,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AXON. Quent Capital LLC boosted its stake in shares of Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC increased its stake in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares in the last quarter. Brooklyn Investment Group bought a new stake in shares of Axon Enterprise in the 3rd quarter valued at $41,000. Planning Capital Management Corp raised its stake in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the period. Finally, Friedenthal Financial bought a new position in Axon Enterprise during the third quarter worth about $51,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other news, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock worth $30,721,337 over the last quarter. 6.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday. JMP Securities upped their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Finally, TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $524.85.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $639.97 on Thursday. The stock has a market capitalization of $48.80 billion, a PE ratio of 165.37, a P/E/G ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a 1-year low of $247.04 and a 1-year high of $698.67. The firm has a fifty day simple moving average of $618.90 and a 200 day simple moving average of $477.78. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.